Alyeska Investment Group
CMTA

Alyeska Investment Group’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Alyeska Investment Group’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-682,400
Closed -$17.8M – 553
2019
Q1 		$17.8M Buy
+682,400
New +$12.7M 0.24% 132
2018
Q3 		– Sell
-225,862
Closed -$2.97M – 572
2018
Q2 		$2.97M Buy
225,862
+56,192
+33% +$910K 0.03% 320
2018
Q1 		$2.57M Buy
169,670
+89,670
+112% +$1.46M 0.02% 332
2017
Q4 		$1.52M Hold
80,000
– – 0.01% 357
2017
Q3 		$1.35M Buy
+80,000
New +$1.31M 0.01% 401

Alyeska Investment Group's CMTA Position: Q2 2019 in Review

Alyeska Investment Group sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 682,400 shares — an estimated $17.8M sold.

Alyeska Investment Group first reported a position in CMTA in Q3 2017 and held it in 5 quarters. The position peaked at $17.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Alyeska Investment Group reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 682,400 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $17.8M.
  • Alyeska Investment Group first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 5 quarters.
  • Alyeska Investment Group's Clementia Pharmaceuticals Inc. position peaked at $17.8M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.